Pneumococcal vaccination in developing countries

This publication has 11 references indexed in Scilit:

• The Impact of a 9-Valent Pneumococcal Conjugate Vaccine on the Public Health Burden of Pneumonia in HIV-Infected and -Uninfected Children
  Clinical Infectious Diseases, 2005
• Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
  The Lancet, 2005
• Bacteremia among Children Admitted to a Rural Hospital in Kenya
  New England Journal of Medicine, 2005
• Invasive Pneumococcal Infections Among Hospitalized Children in Bamako, Mali
  The Pediatric Infectious Disease Journal, 2004
• A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
  New England Journal of Medicine, 2003
• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Estimates of world-wide distribution of child deaths from acute respiratory infections
  Published by Elsevier ,2002
• The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II
  Clinical Infectious Diseases, 2000
• Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I
  Clinical Infectious Diseases, 2000
• Etiology of severe pneumonia in children in developing countries
  The Pediatric Infectious Disease Journal, 1986